'Shark Tank' Host on HIMSS: 'No Idea How All These People' Will 'Make It'
Daymond John from "Shark Tank" made a surprise appearance at a major health tech conference—and remarked on the number of ...
Business Insider16d
Hims is officially phasing out its copycat weight-loss drugs, and the company's stock tumbled — again
Hims and Hers' stock fell over 19% in after-hours trading on Monday after its CEO said the company would no longer sell compounded versions of mega-hit weight loss drugs. "We will have to start ...
Business Insider6d
Hims & Hers bought a skincare startup for $190 million 4 years ago. Today it shut it down.
Hims & Hers is shutting down the dermatology business it acquired four years ago, Business Insider has learned. On Friday, the telehealth company discontinued Apostrophe, the direct-to-consumer ...
Yahoo Finance16d
Why Hims & Hers (HIMS) Stock Is Tumbling
Hims & Hers (HIMS) stock is sinking 20% today after Eli Lilly (LLY) unveiled significantly cheaper versions of its popular weight-loss drugs today. Additionally, the FDA last week hindered the ...
Reuters18d
Hims & Hers warns it may stop selling compounded weight-loss drugs
Feb 24 (Reuters) - Hims & Hers (HIMS.N), opens new tab said on Monday that it may no longer be able to sell compounded versions of the weight-loss drug made by Novo Nordisk (NOVOb.CO), opens new ...
Seeking Alpha20d
Hims & Hers: After A 205% Gain, Downgrading To A Hold, But Options Present An Opportunity
Hims & Hers Health's stock has surged 205% since ... in website and mobile application development and internal-use software" investments in CapEx) gives the stock a price/FCF multiple of ~105x ...